Journal
BIOMARKERS
Volume 19, Issue 4, Pages 259-268Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/1354750X.2014.904001
Keywords
Alzheimer's disease; amyotrophic lateral sclerosis; biofluid markers; microRNA; multiple sclerosis; Parkinson's disease
Categories
Funding
- Danish Advanced Technology Foundation
Ask authors/readers for more resources
MicroRNAs (miRNA) are biological molecules transcribed from non-protein coding regions of the genome, participating in regulating cellular processes. MiRNAs in biofluids may possess neurodegenerative disease biomarker potential for screening tests, differential diagnosis and disease progression monitoring. This systematic review clarifies biomarker potential of miRNAs detected in biofluids of neurodegenerative disease patients. Thirty-three and ten miRNAs displayed significant expression between patients with multiple sclerosis and Alzheimer's disease, respectively, compared to healthy controls in minimum two studies. Thirty-eight miRNAs showed biomarker potential by distinguishing significantly between minimum two diseases. Summarized data directs future research towards discovering new biomarkers for neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available